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We tried to purify a new protein component required for the activation of NADPH oxidase from the guinea pig neutrophil cytosolic fraction which 
did not contain p47@“‘,‘and p67@‘“,*, using HAC-SCP, IEC-QA and Superose I2HR columns. The NADPHoxidase-activating activity was separated 
into three fractions on IEGQA anion-exchange HPLC. However, when each of the fractions was purified by Suprose I2HR gel filtration. the 
active fraction eluted at the same position, and was found to contain a common protein with a molecular weight of 28S kDa on SDS-PAGE. These 
results suggest hat the 28.5 kDa protein is a novel NADPH oxidasc activating protein. 
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1, INTRODUCTION ~47p”“.~ and p67 phus Therefore, in this study, we have 
tried the purificatidn of a new protein from Q&l. 
The superoxide (0;) is essential for microbicidal and 
cytotoxic activities of neutrophils and other profes- 
sional phagocytic ells [l]. 0; is produced by the activa- 
tion of plasma membrane-bound NADPH oxidase, and 
the studies of Oi production using cell-free systems have 
suggested that multiple cytosolic components are re- 
quired for the activation of NADPH oxidase [S-lo]. 
The ~47~““,’ and the ~67~““” are well known as the cy- 
tosolic components of human neutrophils [6,1 l-l 31. Re- 
cently, it has been reported that a cytosolic GTP-bind- 
ing protein is involved in the regulation of the activation 
of NADPH oxidase [14,15]. 
2. MATERIALS AND METHODS 
?. I I Preparotion of nculropi~ifs 
Guinea pig neutrophils were isolated from exudates 13-15 h after 
an intrapcritoneal injc<tion of 0.17% glycopn in 0.9% saline as previ- 
ously described [17]; the purity of the cells was .96%. 
2.2. Prepurotion of cytosoi und rrren~brunefrucrions 
On the other hand, we have separated three cytosolic 
factors (SP-1, QA-1 and QA-2) from guinea pig neutro- 
phils using ion-exchange chromatography, i.e. SP-1 was 
adsorbed on a cation-exchange column, and QA-1 and 
QA-2 were adsorbed on an anion-exchange column, 
and we found that the combination of these factors fully 
activated the NADPH oxidase [IO]. Using immunoblot 
analysis, we have found that SP-1 contains both the 47 
kDa and the 63 kDa proteins which corresponds to 
human p47 Plros and ~67~“““, respectively [16]. On the 
other hand, in preliminary experiments we have ob- 
served that QA-2 contains the 63 kDa protein, whereas 
QA-1 does not contain the proteins corresponding to 
Neutrophils (1x10’ cells/ml) were pretreated with 5 mM diisopropyl 
fluorophosphate in phosphate-butTerod saline (PBS; I37 mM NaCI. 
2.7 mM KCI, 8.1 mM Na:HPO,, 1.5 mM KH$G,, pH 7.4) for 30 min 
at 4°C. After washing with PBS, neutrophils were resuspended in 0.34 
M sucrose buffer (I 3 1 mM NaCI, 8 mM KH!PO,, 0.34 M sucrose. 
containing I mM EGTA, 0,8 mM PMSF, IO pa/ml pepstalin and 50 
p&ml leupeptin, pH 7.0) at 2 x 10” cells/ml. The cells were disrupted 
by sonication in ice, and the cytosol and membrane fractions were 
prepared as described previously [IO]. These fractions were stored at 
-8OOC until use. 
2.3. Purification of cytosolic cmponent 
To change the bulTer. 80 ml ofthccytosolic fraction (containing650 
mg protein) was applied to a Scphadex G-25 column (Pharmacia LKB 
Biotechnology, Sweden) quilibratcd with 20 mM HEPES, FH 7.5. 
containing 0.5 mM EGTA and 0.5 mM PMSF (buffer A),and the void 
fraction was applied to a QsSepharose Fast-Flow column (26 x 120 
mm, Pharmacia LKB Biotechnology) equilibrated with bufTer A. 
AfIer washing with buffer A, the column was cluted with a O-500 mM 
NaCl gradient at a Row rate of 4.0 mUmin. The active fraction (a total 
volume of IO8 ml) obtained from the Q-Sepharose Fast-Flow chrom- 
atography was concentrated using an ultrafilter UK-10 with a molcc- 
ular mass cut-off of 10 kDa (Toy0 Roshi Kaisha, Ltd., Japan) to a 
volume of 20 ml. The concentrated sample was mixed with the two 
volumes of 10 mM sodium phosphate buffer, pH 7.0, containing0.17 
M sucrose, and was applied to a Biofine HAC-SCP hydroxyapatite 
column (7.5 x 75 mm, JASC(EJAPAN Spectroscopic Co,, Ltd,, 
Japan) equilibrated with 10 mM sodium phosphate buffer. pH 7.0, 
containing 0.17 M sucrose, Alter washing with the equilibration 
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Fig. 1 Q-Scpharose Fast-Flow chromatography of the guinea pig neutrophil cytosol fraction. Cytosol fraction (650 mg protein) was applied to a 
QmSepharose Fast-Flow column, and cluted with a O-90 mM NaCl gradient with a fraction size of I2ml. Hundred microliter aliquots were assayed 
for tbc NADPH oxidasesactivating activity. The fractions 40-48 indicated by the bar, were used for further purification, Insert, immunoblot analysis 
with anti-human p47M”’ (p47 Ab) or anti-human p67 mhV (~67 Ab) antibodies. C and numbers (24, 35, 43 and GO) indicate the crude cytosol and 
the fraclion numbers, respectively. 
buffer, the column was clutcd with a linear gradient of IO-300 mM 
sodium phosphate at a flow rate of I .O mlimin. The active fraction was 
rnixLti with 10 volumes of distilled water, and applied to a Biofine 
IEC-QA anion-exchange column (7.5 x 75 mm, JASCO) equilibrated 
with buffer A. The column was eluled with a O-200 mM NaCl gradient 
at a flow rate of 1.0 ml/min. The active fractions were conceniratcd 
using an ultrafilter UK~lG to a volume of 0.6 ml, and applied to a 
Supcrose 12HR gel filtration column (10 x 300 mm, Pharmacia LKB 
Biotechnology) equilibrated with 20 mM sodium phosphate buffer, 
pH 7,0, containing 0.13 M NaCI. 0.5 mM PMSF. and I mM ECTA 
a! a flow rate of 0,s mllmin. 
2.4. Assay OJ he NADPH oxihe-ucfivafing acriviry 
Assay of the NADPH oxidasc was performed in a cell-free system 
using an arachidonic acid as a stimulant [lo]. 
The activity of QA-1 was assayed in the presence of SP-I, because 
QA-1 n&cd SP-1 to show activity [IO]. SP-I was prepared from 100 
mg cytosol fraction by the separation procedure described previously 
[IO], and a threshold amount of SP-1 (about 12 yg) was added in the 
assay mixture. The assay mixture consisted of 200 PM NADPH, 80 
PM cytochromc , 5 mM M&l,, 10yM FAD, 20pM arachidonic 
acid, 15c(g membrane fraction. SP-I (I S-25 ~1) and each fraclion from 
chromatography in the lotal volume of 0.5 ml of 65 mM sodium 
phosphate buffer (pH 7.0) containing 0. Ii M sucrose. The assay was 
performed at 37OC in an Hitachi 557 dual.wavelength spectrophoto- 
meter (Hitachi, Ltd., Japan) and the absorbance difference at 550-540 
nm was followed continuously. The activity was calculated using an 
extinction coefficient of 2.1 x l(r M-‘.cm-I. 
2.5, Polyucryhmide gel ekclropl~oresis 
SDS-PAGE was carried out with a 8-1646 linear gradient gel in the 
presence of 0.1% SDS by the method of Laemmli and Favere [ISj. 
Samp:es were treated with 10 mM dithiothreitol at 100°C for 3 min. 
The gel was silver-stained using a commercially nvailahl.: reagent kit 
(Daiichi Pure Chemicals Co.. Japan). 
Proteins in each fraction were subjected to SDS-PAGE (8-16% gel) 
and were electropboretically transferred to :: riitrocellulosc membrane, 
The membrane was incubaled with a Block Ace (Dainippon Pharma- 
ceutical Co. Lld.,,Japan). and reacted with a I :?OlM dilution of mouse 
anti-human p47”““.’ or anti-human ~67”““.~ monoclonal antibody, or 
with a I:400 dilution or mouse anti-myosin light.chain monoclonal 
antibody (Sigma Chemical Co,, USA), The proteins were detected by 
the incubation with horseradish pcroxidase-conjugaied goat ami- 
mouse IgG followed by development with dirormazan using the POD 
Immunostain Set (Wako Pure Chemical ndustries Ltd,, Japan). 
The sensitivity of the anti-myosin light chain monoclonal antibody 
was examined using partially purified guinea pig macrophagc p21”“, 
and I pmol of ~21”” was detected by the antibody. 
3. RESULTS AND DISCUSSION 
As shown in Fig. 1, two peaks of the activities ap- 
peared on a Q-Sepharose Fast-Flow anion-exchange 
chromatography. One activity was eluted as a broad 
peak over a range from 100 to 190 mM N&I, and 
another activity was eluted at about 250 mM N&l. The 
proteins in these fractions seemed to be anionic judging 
by their adsorption behavior on anion-exchange chrom- 
atography. Furthermore, judging from the elution pat- 
tern the first peak and the second peak seemed to be 
QA, and QA-2, respectively, as described previousty 
[lo]. QA-2 (fraction 40) contained a 63 kDa protein 
reacting with anti-human ~671”“~ antibody, but did not 
contain protein(s) reacting with anti-human p47phu.r an- 
tibody (Fig, 1, insert). These results indicate that guinea 
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Fig, 2. HAC-SCP and IEC-QA chromatographies of the cytosblic 
component. (A) The active fraction from Q-Sepharose Fast-Flow 
chromatography was applied to a HAC-SCP column, and eluted with 
a sodium phosphate gradient Gth a fraction size of I ml. Hundred 
microliter aiiquois were assayed for the NADPH oxidasc.activating 
activity. The ban indicate the fractions that were used for further 
purification. (B) Fractions 12-I 5 obtained liom the HAC-SCP HPLC 
were applied to a IEC-QA column, and eluted with a O-200 mM NaCl 
gradient with a fruction size of 1 ml. i4undred microlitcr aliquots were 
assayed for the NADPH oxidase-activating activity. Fractions 8-10, 
fractions 16-l 8 and fractions 19-21 were designated as Peak I. Peak 
‘II and Peak III. respectively, 
pig neutrophils also contain the 63 kDa NADPH oxi- 
dase-activating protein corresponding to human 
~67~““.~, as reported in bovine neutrophils [19,20]. On 
the other hand, QA-I (fractions 24, 35 and 43) did not 
react with anti- human p47@“” and anti-human p67”““,’ 
antibodies, indicating that QA-1 is a new cytosoiic fac- 
tor which does not contain the protein(s) corresponding 
to human p47P”“” and human p67@.‘. The fractions 40- 
48 were further purified by a HAC-5CP hydroxyapatite 
column (Fig. 2A), because these fractions contained ht- 
tle contaminating protein. Then, the active fractions 
were applied to a IEC-QA anion-exchange column (Fig. 
2B). As seen in the figure, the three active peaks were 
eluted at about 40 mM, 90 mM and 110 mM NaCI, and 
were designated as Peak I, Peak II and Peak III, respec- 
tively. Each of the peaks was applied to a Superose 
12WR gel filtration column. 
Peak I was eluted as a single peak with an apparent 
molecular weight of 49 kDa, which contained a single 
protein band with a molecular weight of 28.5 kDa on 
SDS-PAGE (Fig, 3A). Peak 11 (Fig. 311) and Peak III 
(Fig. 3C) were also eluted with an apparent molecular 
weight of 49 kDa. SDS-PAGE analysis showed that 
these active fractions also cobtai;red the 28.5 kDa j?iO- 
tein band, and that the density of this protein band 
paralleled the NADH oxidase-activating activity. These 
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Fig. 3. Superose 12HR chromatography of Peaks I, II and III. Three 
active peaks obtained from IEC-QA HPLC were putilied on a Super- 
ose I2HR column with a fraction size of 0.5 ml. A. Band C indicate 
the elution profiles of Peak I, Peak 11 and Peak HI. respectively. One 
hundred and fifty atiquots were assayed for the NADPH oxidase- 
activating activity. Insert, SDS-PAGE analysis of the fractions 51. 53. 
55,57 and 59. Molecular weight standards: phosphorylasc b (94 kDa), 
albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), 
trypsin inhibitor (20,l kDa), a-ldctalbumin (14.4 kDa). The arrows 
show the position of the 28.5 kDa protein. 
observations indicate that t!le 28.5 kDa protein is an 
essential component of QA-1, 
Abo et al. have purified a third component (61) from 
guinea pig macrophages 1211, which is composed of a 
small GTP-binding protein ~21”” (22 kDa protein) and 
a GDP-dissociation inhibitor rhoGDI(26 kDa protein), 
and suggested that ~21 mrf is the active component of 81, 
based on the results of the effect of recombinant ~21”” 
on NADPH oxidase activity [14]. Recently, a small 
GTP-binding protein ~21”‘‘-’ (22 kDa protein) has been 
reported to be a cytosolic regulatory component of the 
NADPH oxidase in human neutrophils [15]. The Or- 
producing activities of ~21“‘~’ and ~21”‘~ have been 
reported to be depcndcnt on GTP [14,! 5’j. However, the 
NADPH oxidase-activating activity of the 28.5 kDa 
protein was hardly potentiated by the addition of l-80 
71 
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yM GTPyS (data not shown), Furthermore, we ob- 
served that the 28.5 kDa protein (2 pmol) did not react 
with the anti-myosin light chain antibody which reacted 
with p-1 3 ‘a” [14]. From the differences in molecular 
weights, the dependence of GTP and the reactivity 
against he antibody, the 28.5 kDa protein seems to be 
a new active component different from the GTP-bind- 
ing proteins. 
We have observed that SP- 1, QA- 1 and QA-2 activate 
the NADPH oxidase synergistically [lo]. SP-1 con- 
tained the 47 kDa and the 63 kDa proteins correspond- 
ing to human ~47~““” and human p6?““, respectively 
[lci]. On the other hand, QA-2 contained the 63 kDa 
protein. Therefore, it seems to be possible that the 28.5 
kDa protein, an essential component of QA- 1, activates 
the NADPH oxidase through the interaction with the 
47 kDa and/or the 63 kDa proteins, The detailed mech- 
anism by which the 28.5 kDa protein activates the 
NADPH oxidase must be studied further, 
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